Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study

View through CrossRef
Medulloblastoma and pilocytic astrocytoma are the two most common pediatric brain tumors with overlapping imaging features. In this proof-of-concept study, we investigated using a deep learning classifier trained on a multicenter data set to differentiate these tumor types. We developed a patch-based 3D-DenseNet classifier, utilizing automated tumor segmentation. Given the heterogeneity of imaging data (and available sequences), we used all individually available preoperative imaging sequences to make the model robust to varying input. We compared the classifier to diagnostic assessments by five readers with varying experience in pediatric brain tumors. Overall, we included 195 preoperative MRIs from children with medulloblastoma (n = 69) or pilocytic astrocytoma (n = 126) across six university hospitals. In the 64-patient test set, the DenseNet classifier achieved a high AUC of 0.986, correctly predicting 62/64 (97%) diagnoses. It misclassified one case of each tumor type. Human reader accuracy ranged from 100% (expert neuroradiologist) to 80% (resident). The classifier performed significantly better than relatively inexperienced readers (p < 0.05) and was on par with pediatric neuro-oncology experts. Our proof-of-concept study demonstrates a deep learning model based on automated tumor segmentation that can reliably preoperatively differentiate between medulloblastoma and pilocytic astrocytoma, even in heterogeneous data.
Title: Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study
Description:
Medulloblastoma and pilocytic astrocytoma are the two most common pediatric brain tumors with overlapping imaging features.
In this proof-of-concept study, we investigated using a deep learning classifier trained on a multicenter data set to differentiate these tumor types.
We developed a patch-based 3D-DenseNet classifier, utilizing automated tumor segmentation.
Given the heterogeneity of imaging data (and available sequences), we used all individually available preoperative imaging sequences to make the model robust to varying input.
We compared the classifier to diagnostic assessments by five readers with varying experience in pediatric brain tumors.
Overall, we included 195 preoperative MRIs from children with medulloblastoma (n = 69) or pilocytic astrocytoma (n = 126) across six university hospitals.
In the 64-patient test set, the DenseNet classifier achieved a high AUC of 0.
986, correctly predicting 62/64 (97%) diagnoses.
It misclassified one case of each tumor type.
Human reader accuracy ranged from 100% (expert neuroradiologist) to 80% (resident).
The classifier performed significantly better than relatively inexperienced readers (p < 0.
05) and was on par with pediatric neuro-oncology experts.
Our proof-of-concept study demonstrates a deep learning model based on automated tumor segmentation that can reliably preoperatively differentiate between medulloblastoma and pilocytic astrocytoma, even in heterogeneous data.

Related Results

Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract Medulloblastoma is the most common malignant brain tumor in children. Currently, treatment consists of surgical resection, chemotherapy, and whole brain and...
Pilocytic Astrocytoma Cerebellum
Pilocytic Astrocytoma Cerebellum
Tumor intrakranial dapat timbul di dalam rongga tengkorak baik di dalam kompartemen supratentorial maupun infratentorial.. Pasien mengeluh nyeri kepala dan kadang pusing ketika ber...
Data from PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
Data from PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
<div>Abstract<p>Intratumor epigenetic heterogeneity is emerging as a key mechanism underlying tumor evolution and drug resistance. Epigenetic abnormalities frequently o...
Data from PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
Data from PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma
<div>Abstract<p>Intratumor epigenetic heterogeneity is emerging as a key mechanism underlying tumor evolution and drug resistance. Epigenetic abnormalities frequently o...

Back to Top